TCM Biotech International Statistics

Total Valuation

TCM Biotech International has a market cap or net worth of TWD 3.44 billion. The enterprise value is 2.98 billion.

Market Cap	3.44B
Enterprise Value	2.98B

Important Dates

The next estimated earnings date is Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	Aug 28, 2024

Share Statistics

TCM Biotech International has 59.05 million shares outstanding. The number of shares has increased by 18.23% in one year.

Current Share Class	n/a
Shares Outstanding	59.05M
Shares Change (YoY)	+18.23%
Shares Change (QoQ)	+3.52%
Owned by Insiders (%)	21.17%
Owned by Institutions (%)	1.85%
Float	38.68M

Valuation Ratios

The trailing PE ratio is 168.82 and the forward PE ratio is 42.79.

PE Ratio	168.82
Forward PE	42.79
PS Ratio	4.05
PB Ratio	3.28
P/TBV Ratio	3.30
P/FCF Ratio	72.40
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.88, with an EV/FCF ratio of 62.87.

EV / Earnings	149.18
EV / Sales	3.58
EV / EBITDA	62.88
EV / EBIT	113.05
EV / FCF	62.87

Financial Position

The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.12.

Current Ratio	6.03
Quick Ratio	4.68
Debt / Equity	0.12
Debt / EBITDA	2.54
Debt / FCF	2.54
Interest Coverage	11.64

Financial Efficiency

Return on equity (ROE) is 2.51% and return on invested capital (ROIC) is 1.77%.

Return on Equity (ROE)	2.51%
Return on Assets (ROA)	1.55%
Return on Capital (ROIC)	1.77%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.79
Inventory Turnover	2.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.53%
50-Day Moving Average	59.82
200-Day Moving Average	57.21
Relative Strength Index (RSI)	34.15
Average Volume (20 Days)	155,501

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TCM Biotech International had revenue of TWD 834.32 million and earned 20.00 million in profits. Earnings per share was 0.34.

Revenue	834.32M
Gross Profit	411.45M
Operating Income	26.40M
Pretax Income	23.68M
Net Income	20.00M
EBITDA	43.83M
EBIT	26.40M
Earnings Per Share (EPS)	0.34

Full Income Statement

Balance Sheet

The company has 573.32 million in cash and 120.64 million in debt, giving a net cash position of 452.68 million or 7.67 per share.

Cash & Cash Equivalents	573.32M
Total Debt	120.64M
Net Cash	452.68M
Net Cash Per Share	7.67
Equity (Book Value)	1.05B
Book Value Per Share	17.75
Working Capital	770.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 50.30 million and capital expenditures -2.83 million, giving a free cash flow of 47.47 million.

Operating Cash Flow	50.30M
Capital Expenditures	-2.83M
Free Cash Flow	47.47M
FCF Per Share	0.80

Full Cash Flow Statement

Margins

Gross margin is 49.32%, with operating and profit margins of 3.16% and 2.40%.

Gross Margin	49.32%
Operating Margin	3.16%
Pretax Margin	2.84%
Profit Margin	2.40%
EBITDA Margin	5.25%
EBIT Margin	3.16%
FCF Margin	5.69%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.49%.

Dividend Per Share	0.29
Dividend Yield	0.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	8.09%
Buyback Yield	-18.23%
Shareholder Yield	-17.74%
Earnings Yield	0.59%
FCF Yield	1.38%

Dividend Details

Stock Splits

The last stock split was on July 20, 2023. It was a forward split with a ratio of 1.0306.

Last Split Date	Jul 20, 2023
Split Type	Forward
Split Ratio	1.0306

Scores

TCM Biotech International has an Altman Z-Score of 10.48.

Altman Z-Score	10.48
Piotroski F-Score	n/a